معرفی
Nicholas A. Blondin, MD, is an Associate Professor of Neurology at Yale School of Medicine (Yale University). He specializes in Neuro-Oncology, treating patients at Smilow Cancer Hospital in New Haven and Trumbull. His clinical expertise includes brain tumors, metastasis, and neurological complications of cancer. Dr. Blondin leads clinical trials through Yale Cancer Center, focusing on novel therapies for glioblastoma and leptomeningeal disease.
Education:
- BA in Chemistry, Wesleyan University
- MD, University of Connecticut School of Medicine
- Internship and Neurology Residency, Yale School of Medicine (Chief Resident)
- Neuro-Oncology Fellowship, Yale New Haven Hospital
Research Interests: Dr. Blondin's work spans neuro-imaging (deuterium metabolic imaging), clinical trials for brain tumors (GBM AGILE platform), molecular characterization of metastases, and therapeutic innovations including tumor-treating fields and liquid biopsy applications.
Awards:
- Connecticut Brain Tumor Alliance Humanitarian Award (2018)
- Gold Humanism Honor Society (2013)
- Palatucci Advocacy Leadership Forum Graduate (2014)
Clinical Trials & Leadership: He serves as Principal Investigator for multiple trials, including studies on VAL-083 for glioblastoma and CSF circulating tumor cell assays. Collaborates with neurosurgeons, radiation oncologists, and translational researchers at Smilow Cancer Hospital.